Predict RA
Study area: Rheumatology
Aim: To assess the impact on patients with rheumatoid arthritis if their dose of adalimumab (Humira) is reduced or withdrawn
Who can participate: Over 18, taking Adalimumab (Humira) for Rheumatoid Arthritis and for their disease to be well controlled.
DCVAS
Study area: Rheumatology
Aim: To develop new diagnostic and classification criteria for the different types of primary vasculitis. The study will allow us to improve our ability to distinguish patients with vasculitis from those who do not have it, and to distinguish between the different forms of vasculitis.
Who can participate: Patients over 18 years old, a new or established (within two years) diagnosis of vasculitis, possible diagnosis of vasculitis, and comparator group.
BSRBR
Study area: Rheumatology
Aim: Observational study to collect long term information on Biologic therapy.
Who can participate: Anyone diagnosed with Rheumatoid arthritis who have started a biological drug within the last 6 months, patients must be aged 18 years or over.
Giant Cell Arteritis (GCA) Sightloss
Study area: Rheumatology
Aim: Patients diagnosed with Giant Cell Arteritis invited to allow researchers to share clinical data with Southend University Hospital on their diagnosis and symptoms of GCA, with or without sight loss. To find out the incidence of non-sight loss and sight loss GCA.
